Genetic Technologies Limited - ADR (GENE) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Genetic Technologies Limited - ADR Company Snapshot

Business Description:

Genetic Technologies Limited - ADR operates in the Biological products exc. diagnostic sector. Genetic Technologies Limited is engaged in a diagnostic product business. The Company translates genetic tests into products and services. The Company's cancer diagnostics business focused on building a sustainable stable of products and services. The Company operates in three divisions: genetic testing, including cancer diagnostics; licensing, and research. BREVAGen provides a personalized genetics based risk score for such women, so guiding preventive therapy or advanced monitoring decisions. The majority of its customers are clinicians. The Company's five overseas subsidiaries include Gtech International Resources Limited, Genetic Technologies (Beijing) Limited, GeneType AG, GeneType Corporation and Phenogen Sciences Inc. In April 2010, Genetic Technologies acquired the assets of Perlegen Sciences Inc., which included non-familial breast cancer risk assessment test BREVAGen.

Stock Performance Chart for Genetic Technologies Limited - ADR

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 4.08
(Figures in U.S. Dollars)

1 Week	-3.8%	13 Weeks	16.6%

4 Weeks	1.7%	52 Weeks	24.5%

Genetic Technologies Limited - ADR Key Data:

Ticker:	GENE	Country:	AUSTRALIA

Exchanges:	NAS	Major Industry:	Miscellaneous

		Sub Industry:	Medical Services

2011 Sales	4,598,131 (Year Ending Jan 2012).	Employees:	54

Currency:	U.S. Dollars	Market Cap:	63,186,301

Fiscal Yr Ends:	June	Shares Outstanding:	15,486,838

Share Type:	Ordinary	Closely Held Shares:	7,052,851

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.